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Abstract
Background:  Listeria monocytogenes is a well-characterized food-borne pathogen that infects
pregnant women and immunocompromised individuals. Listeriolysin O (LLO) is the major
virulence factor of the pathogen and is often used as a diagnostic marker for detection of L.
monocytogenes. In addition, LLO represents a potent antigen driving T cell-mediated immunity
during infection. In the present work, Lactococcus lactis NZ9000 was used as an expression host to
hyper-produce LLO under inducible conditions using the NICE (NIsin Controlled Expression)
system. We created a modified pNZ8048 vector encoding a six-His-tagged LLO downstream of
the strong inducible PnisA promoter.
Results: The constructed vector (pNZPnisA:CYTO-LLO) was expressed in L. lactis NZ9000 and
was best induced at mid-log phase with 0.2% v/v nisin for 4 h statically at 30°C. Purification of the
His-tagged LLO was accomplished by Ni-NTA affinity chromatography and functionality was
confirmed through haemolytic assays. Total LLO yield (measured as total protein content) was
4.43–5.9 mg per litre culture and the haemolytic activity was still detectable after 8 months of
storage at 4°C.
Conclusion:  The LLO production method described in this work provides an approach to
efficient LLO production in the Gram-positive Lactococcus bacterium to yield a significant source of
the protein for research and diagnostic applications. Expression of LLO in L. lactis has a number of
benefits over E. coli which may facilitate both in vivo and in vitro applications of this system.
Background
Listeria monocytogenes is the causative agent of listeriosis, a
food-borne disease generally associated with the con-
sumption of contaminated ready-to-eat food products.
Listeriosis affects mainly immunocompromised individu-
als and the outcome of infection includes spontaneous
miscarriage in pregnant women, and meningitis in the
newborn [1]. L. monocytogenes is common in the environ-
ment and can be found in the gastrointestinal tract of
approximately 5% of healthy persons. Symptomatic infec-
tion occurs in individuals with immunosuppression
including patients with AIDS and organ transplant recipi-
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ents [2]. Listeriosis is usually a severe disease with a mean
mortality rate in humans of 20 to 30% [3]. Several com-
mon-source outbreaks of listeriosis have been linked to
consumption of Listeria-contaminated foods (frankfurt-
ers, pâté, pasteurised milk and soft-cheese) [2]. Control-
led good manufacturing procedures and early detection of
Listeria contamination in food are of great importance in
preventing such outbreaks.
The major virulence factor of L. monocytogenes is the
haemolysin listeriolysin O (LLO). Upon internalisation of
the bacterium within the host cell phagolysosome, rapid
acidification (~pH 5.5) activates LLO. The protein then
interacts with vacuolar membrane cholesterol, oligomer-
izes and produces pores in the phagolysosomal mem-
brane permitting bacterial escape to the cytoplasm [3].
LLO is therefore critical to L. monocytogenes infection as it
facilitates intracellular pathogenesis and subsequent
spread of the infection to other tissues.
Enhanced expression systems for in vitro production of
LLO have a number of potential applications. Since LLO
is associated solely with the pathogenic strain L. monocy-
togenes, the use of anti-LLO antibodies to identify the
pathogen in diagnostic or food samples has demonstrated
significant potential [4]. Pure LLO could also find an
application in assays to determine prior exposure and
immunity to the pathogen in humans or animals [5].
Finally, LLO is recognised as an immunodominant anti-
gen by T cells generated during infection [6]. Modified
strains expressing LLO may therefore have applications as
vaccines for delivering this Listeria-specific antigen to the
host immune system.
We have chosen to utilise Lactococcus lactis as a vector for
hyper-expressing LLO. L. lactis is a GRAS (generally
regarded as safe) microorganism widely used in the food
industry. Recent advances in the molecular characteriza-
tion of L. lactis and the development of L. lactis-compati-
ble genetic engineering tools have increased the versatility
of this organism as a means of protein production [7-9].
Moreover, the use of lactococci has been extended by oth-
ers as a live antigen and therapeutic drug delivery system
[10,11]. Several protein expression systems, both consti-
tutive and inducible, have been developed in lactococci
[8]. However, constitutive systems have a potential disad-
vantage in that the protein may be more liable to lactococ-
cal degradation, or may prove toxic to the cell if produced
in high amounts for extended periods.
One of the best characterized inducible expression sys-
tems for use in lactococci is the NICE (NIsin Controlled
Expression) system [12,13]. In the present work, we
describe high level production of the L. monocytogenes LLO
protein in Lactococcus lactis NZ9000 using the NICE sys-
tem. The His-tagged LLO was purified by Ni-NTA affinity
chromatography to give a considerable yield and high
functional haemolytic activity compared to other pub-
lished methods [14,15]. The significant yield and purity
obtained for LLO using the NICE-expression system in
Lactococcus demonstrate the benefits of this approach for
the production of LLO for research and diagnostic pur-
poses. Moreover, the constructed LLO-expressing L. lactis
strain has the potential to act as a safe live vaccine candi-
date against listeriosis.
Methods
Culture media, antibiotics and incubation conditions
For L. lactis, GM17 broth (M17 broth (Oxoid) supple-
mented with 0.5% glucose) was used as a standard culture
medium. Luria-Bertani (LB) broth (10 g peptone from
casein, 5 g yeast extract and 5 g sodium chloride per litre)
was used for Escherichia coli cultures. Solid media were
prepared by adding technical agar (Merck) to the corre-
sponding broth with a final concentration of 1.5% w/v. L.
lactis cultures were incubated statically at 30°C while E.
coli was incubated at 37°C with shaking when applicable.
When required, ampicillin (Amp) was used at a concen-
tration of 100 μg/ml for E. coli while chloramphenicol
(Cm) was used at 10 μg/ml for both E. coli and L. lactis.
Construction of plasmid vector for expression of LLO in L. 
lactis NZ9000
Bacterial strains and vectors used in the present study are
described in Table 1 while PCR primers are summarized
in Table 2. High fidelity KOD hot start DNA polymerase
(Novagen) was used in all PCR reactions throughout the
whole procedures following manufacturer's instructions.
Restriction enzymes and T4 DNA ligase were purchased
from Roche Diagnostics (Mannheim, Germany). The gene
encoding listeriolysin O, hly, of L. monocytogenes EGD-e
was PCR-amplified without the signal peptide coding
sequence from the chromosomal DNA [GenBank:
AL591824] using primers 1 and 2. The resulting PCR
product was sequentially digested by BamHI and PstI
respectively. Ligation to a similarly digested pQE30 vector
(Qiagen) was successfully performed using T4 DNA
ligase. The ligation reaction mixture was transformed into
chemically-competent  E. coli BL21 (Novagen) by heat
shock following manufacturer's instructions and plated
onto LB agar containing 100 μg/ml ampicillin. Positive
colonies were identified by PCR and plasmid was
extracted from BL21 using Qiagen Miniprep Kit (Qiagen).
The resulting plasmid (pQE30/hly) had an N-terminus
six-histidine tagged hly gene and the correct nucleotide
sequence was confirmed by DNA sequencing (Lark Tech-
nologies Inc., UK). pQE30/hly was utilised as a template
for further cloning steps outlined below.Microbial Cell Factories 2008, 7:24 http://www.microbialcellfactories.com/content/7/1/24
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The lactococcal plasmid pNZ8048 [13] was manipulated
to allow insertion of the His-tagged hly  gene. Plasmid
pNZ8048 contains the PnisA promoter (nisin inducible)
with a downstream start codon (ATG) inside an NcoI
restriction site (CCATGG). However, since the hly gene
contains an internal NcoI restriction site, we modified
pNZ8048 to eliminate this NcoI site and added a new start
codon in frame with hly gene. The Splicing by Overlap
Extension (SOE) technique [16] was used to construct an
insert containing the His-tagged hly gene spliced directly
to PnisA promoter without the need for NcoI digestion.
Two PCR reactions were initially performed: primers 3
and 4 were used to amplify the PnisA promoter from
pNZ8048 while primers 5 and 6 were used to amplify hly
(along with the His-tag) from the constructed pQE30/hly
plasmid. The hybrid primers 4 and 5 had overhangs
(Table 2) which allow the overlap of the previous two
PCR products upon combination for the third splicing
PCR reaction. This third PCR reaction was done by com-
bining the initial two PCR products in a molar ratio of 1:1
and again PCR-amplified using primers 3 and 6. The
resulting PCR spliced product (PnisA with downstream
His-tagged  hly) was sequentially digested by BglII and
KpnI respectively. pNZ8048 was similarly digested with
those two restriction enzymes, to remove the PnisA pro-
moter along with the NcoI site, and the digested plasmid
Table 1: Bacterial strains and plasmid vectors used in the present study
Strain or plasmid
 name
Description Reference
 or source
E. coli Top10 Chemically-competent intermediate host, plasmid free Invitrogen
E. coli BL21 Chemically-competent E. coli, used in this study as an intermediate host for pQE30, 
plasmid free
Novagen
Listeria monocytogenes EGD-e serovar 1/2a Wild type Listeria monocytogenes [32]
Lactococcus lactis NZ9700 Nisin producer strain [13]
Lactococcus lactis NZ9000 L. lactis subsp. Cremoris MG1363 carrying nisRK on the chromosome [13]
L. lactis NZ9000 (pNZPnisA:CYTO-LLO) Lactococcus lactis NZ9000 harbouring pNZPnisA:CYTO-LLO plasmid and over-expressing 
LLO upon nisin induction
This study
pQE30 Expression vector using phage T5 promoter and adding an N-terminus six-His tag to the 
expressed protein, AmpR (ampicillin resistant)
Qiagen
pQE30/hly pQE30 vector with hly gene (without signal sequence) inserted between BamHI and PstI 
restriction sites.
This study
pNZ8048 E. coli-L. lactis shuttle vector containing PnisA promoter and start codon in NcoI site, CmR 
(chloramphenicol resistant)
[13]
pNZPnisA:CYTO-LLO Modified pNZ8048 containing PnisA promoter (NcoI site eliminated) with downstream 
His-tagged hly gene, CmR
This study
Table 2: Oligonucleotide primers used in this study.
Primer
code
  number
Primer
 name
Primer sequence (5'-3') (restriction enzyme site or overhang)a
1p Q E 3 0
forward 
primer
GAAGGATCCGATGCATCTGCATTCAATAAAG (BamHI site)
2p Q E 3 0
reverse
primer
ACGCCTGCAGTTCGATTGGATTATCTACTTTATTA (PstI site)
3P n i s A
forward
primer
CCAAGATCTAGTCTTATAACTATACTG (BglII site)
4P n i s A
reverse
primer
(hly overhang)
GGTGATGTCCCATTTTGAGTGCCTCCTTATAATTTATTTTG (hly overhang)
5 hly forward
primer
(PnisA overhang)
AGGCACTCAAAATGGGACATCACCATCACCATCACGGA (PnisA overhang)
6 hly reverse
primer
AGTCGGTACCTTATTCGATTGGATTATCTAC (KpnI site)
(a) Restriction enzyme recognition sites are italicized and underlined while SOE overhangs are underlined.Microbial Cell Factories 2008, 7:24 http://www.microbialcellfactories.com/content/7/1/24
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was agarose gel purified using the Qiagen gel extraction kit
(Qiagen). The spliced PCR product was ligated into the
digested pNZ8048 using T4 DNA ligase. The ligation reac-
tion was transformed into chemically-competent E. coli
TOP10 (Invitrogen) following the manufacturer's instruc-
tions and plated onto LB agar containing 10 μg/ml chlo-
ramphenicol. After incubation at 37°C for 24–48 h,
positive colonies were detected by colony PCR and plas-
mid (designated pNZPnisA:CYTO-LLO) was extracted and
correct DNA sequence was confirmed (Lark Technologies
Inc., UK). Plasmid pNZPnisA:CYTO-LLO was trans-
formed to electrocompetent L. lactis NZ9000, prepared as
previously described [17], using Gene Pulser (Biorad) and
plated onto GM17 agar containing 10 μg/ml chloram-
phenicol. After 24 h incubation at 30°C, colonies were
checked by colony PCR and one positive colony was
stocked for protein induction and expression. Figures 1
and 2 show an overview of the plasmid vector construc-
tion and the sequence of DNA and amino acids of the
final His-tagged LLO respectively.
Schematic representation of the construction of the pNZPnisA:CYTO-LLO vector Figure 1
Schematic representation of the construction of the pNZPnisA:CYTO-LLO vector.
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Protein induction
Filter-sterilized culture supernatant of the nisin-secreting
strain L. lactis NZ9700 was used as a source of nisin [18].
Sterile culture supernatant of L. lactis NZ9700 was stored
in small aliquots at -20°C and one aliquot was thawed
and used as required. The use of the same filter-sterilized
batch of supernatant throughout the study ensured con-
sistency of the nisin content between induction experi-
ments. Overnight culture of L. lactis NZ9000
(pNZPnisA:CYTO-LLO) was subcultured into fresh GM17
broth (Cm 10 μg/ml) and incubated statically at 30°C.
Nisin was added when the optical density at 600 nm
(OD600) reached 0.5. Induction was conducted statically
at 30°C after which cells were pelleted (3200 × g for 10
min) and washed once with buffer (50 mM NaH2PO4,
300 mM NaCl, 10 mM imidazole, pH 8). Pellets were fro-
zen at -80°C prior to sodium dodecylsulphate-polyacryla-
mide gel electrophoresis (SDS-PAGE) or protein
purification.
SDS-PAGE and Western blot
Frozen induced pellets from 500 ml cultures were thawed
on ice and resuspended in 10–15 ml ice-cold lysis buffer
(50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH
8) containing 30 mg/ml lysozyme (Sigma) and kept for
30 min on ice. This was followed by sonication at maxi-
mum amplitude (Soniprep 150, MSE UK Ltd.) using eight
ten-second pulses with intervening ten-second pauses on
ice. For small volume cultures (10–50 ml), pellets were
resuspended in 500 μl lysis buffer in eppendorf tubes and
acid-washed glass beads (Sigma) were added followed by
beating the tubes in a bead beater (Mini beadbeater-8,
Biospec products) for three one-minute beats with one-
minute pauses in between on ice. Clear supernatant was
obtained after centrifugation at 10000 × g for 30 min at
4°C.
For SDS-PAGE, 12% SDS-polyacrylamide separating gel
and 4% stacking gel were used and gels were stained with
coomassie blue stain followed by destaining and gel imag-
ing. For Western blot, pre-stained protein marker was
used (Amersham Biosciences UK, Ltd) and gels were blot-
ted against a nitrocellulose membrane (Hybond-ECL™,
Amersham Biosciences UK, Ltd.) using a semi-dry Western
transfer apparatus. Membranes were blocked overnight at
4°C in 5% skimmed milk in TBS buffer (0.8% NaCl, 20
mM Tris-HCl, pH 7.6). Primary rabbit anti-LLO antibody
(Diatheva, Italy) and secondary anti-rabbit antibody
(Amersham ECL Western Blotting System) were used at 1/
1000 and 1/1500 dilutions in 5% and 10% skimmed milk
in TBS buffer respectively. Western blot detection was
done using Amersham ECL Western Blotting System
(Amersham Biosciences UK, Ltd.) using the protocol rec-
ommended by the manufacturer.
Protein purification and quantitation
Clear supernatant obtained after cell lysis (performed as
described in the previous section) was passed through a
disposable chromatography column (Biorad) containing
2 ml Ni-NTA affinity gel (Qiagen). Column was washed
twice with wash buffer (50 mM NaH2PO4, 300 mM NaCl,
20 mM imidazole, pH 8) then eluted in fractions of 0.5 ml
with elution buffer (50 mM NaH2PO4, 300 mM NaCl,
250 mM imidazole, pH 8). Elutions were checked by SDS-
PAGE and combined together and dialysed overnight at
4°C against 2 l of dialysis buffer (500 mM NaCl, 10 mM
Na2HPO4, 0.5 mM EDTA, 0.02% NaN3, pH 7.0). Listeri-
olysin O concentration was measured as total protein con-
centration by Micro Lowry total protein kit (Sigma) and
also by absorbance at 280 nm using the molar extinction
coefficient for His-tagged LLO as 71,950 cm-1 (calculated
based on the actual sequence of the His-tagged LLO) [19].
The purified protein was stored at 4°C.
Measurement of haemolytic activity of purified LLO
Haemolytic activity of LLO was measured according to the
method described by Khoda et al [20] with slight modifi-
cation. Briefly, defibrinated sheep blood was centrifuged
at 800 × g for 10 min at 4°C, then washed twice with
phosphate buffered saline (PBS) (Gibco) pH 5.5. The pel-
leted red blood cells (RBCs) were diluted with PBS (pH
5.5) to obtain 0.5% RBCs volume/volume (v/v). Aliquots
of 100 μl of the RBCs suspension were distributed in 1.5
ml tubes and twofold serial dilutions of LLO (in PBS pH
5.5) was added to each tube to a final volume of 1 ml. LLO
final concentrations covered the range from 8 μg ml-1 to
29 pg ml-1. A positive control (distilled water, 100%
haemolysis) and a negative control (PBS pH 5.5) were
also included. Tubes were incubated statically at 37°C for
45 min after which they were centrifuged at 1700 × g for 5
min and supernatants were collected. Absorbance was
measured colorimetrically at 415 nm and haemolytic
units were calculated. One haemolytic unit (HU) was
defined as the amount of protein required to cause 50%
haemoglobin release from sheep RBCs as compared to the
100% haemoglobin release of the positive control (dis-
tilled water) [20].
Results
DNA sequence of the six His-tagged hly gene
Native LLO secreted by Listeria monocytogenes EGD-e is
composed of a secretory signal peptide (25 amino acids)
and the actual active portion of LLO (504 amino acids). In
the cloning described in this paper we omitted the native
secretory signal sequence (coding for the first 25 amino
acids) of LLO and added six histidine amino acids (a His-
tag) at the N-terminus (Figure 2). DNA sequencing of the
constructed pNZPnisA:CYTO-LLO confirmed the addi-
tion of the six-His-tag upstream of the hly gene and the
integrity of the remainder of the hly gene sequence. Over-Microbial Cell Factories 2008, 7:24 http://www.microbialcellfactories.com/content/7/1/24
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all we added a total of 10 amino acids (including the 6
histidine residues) at the N-terminus of LLO, in place of
the signal sequence, to facilitate tagging and purification
of the protein (Figure 2). These few amino acids did not
affect protein activity as shown below.
Nisin-induced LLO production in L. lactis NZ9000 
(pNZPnisA:CYTO-LLO)
We performed a series of induction experiments on L. lac-
tis NZ9000 (pNZPnisA:CYTO-LLO) to determine the opti-
mum conditions for protein expression. Preliminary
induction time-course experiments showed the optimum
duration for nisin-induction to be 3–4 h (data not
shown). Consequently, induction was performed at mid-
log phase (OD600 = 0.5) for three hours. Initially, differ-
ent nisin concentrations were examined: 0.02%, 0.1%,
and 0.2% (v/v), to determine the optimum concentration
for induction and SDS-PAGE was performed to assess the
amount of LLO produced (Figure 3A). Subsequently, for
protein over-production experiments, 0.2% v/v nisin con-
centration was chosen for induction to maximize the
amount of LLO produced. Western blot was also per-
formed and confirmed the production of pure non-
degraded LLO (Figure 3B). It is noteworthy that we
detected minimal basal expression of LLO in the unin-
duced L. lactis NZ9000 (pNZPnisA:CYTO-LLO) with no
apparent toxicity on bacterial growth (data not shown).
The inducer of basal PnisA activity in our experiments in
the absence of nisin is not clear although other inducers
such as lactose and galactose have been previously
reported to induce this promoter at low levels [21]. In our
experiments the basal LLO expression was negligible com-
pared to the amount of LLO produced upon nisin induc-
tion.
Purification of LLO and total protein quantitation
To obtain rapid and reproducible purification of LLO, we
used the Ni-NTA technology to capture and purify the six-
His-tagged protein by affinity chromatography under
native purification conditions. Figure 4 shows a represent-
ative purification procedure of the His-tagged LLO (about
57 kDa) checked by SDS-PAGE. The average yield of pure
LLO (measured as total protein) after 3 h-induction at
30°C using a concentration of 0.2% v/v of nisin was 3 mg
per litre culture as measured by both Lowry and A280
absorbance methods. When the induction time was
increased to 4 h at 30°C, the yield ranged from 4.43–5.9
mg per litre culture. However, to increase the total yield of
LLO, we modified the LLO extraction method by applying
double sonication to the 4 h-induced pellets of L. lactis
NZ9000 (pNZPnisA:CYTO-LLO). In brief, after the first
sonication was completed (as described in the Methods
section), the supernatant was collected for Ni-NTA purifi-
cation and the remaining pellets were frozen again at -
20°C for 24 hours then thawed, resuspended in lysis
buffer and sonicated again. Supernatant was collected and
then Ni-NTA-gel-purified. This second sonication of the
same pellets simply extracted LLO which had not been
released from Lactococcus cells upon the first treatment.
Eluted proteins from the two sonication treatments were
Illustrative partial DNA and amino acid sequence of the constructed vector and LLO respectively Figure 2
Illustrative partial DNA and amino acid sequence of the constructed vector and LLO respectively. (A) Illustrative 
DNA sequence of the SOE (splicing by overlap extension) PCR product consisting of the PnisA promoter spliced to down-
stream six-His-tagged hly gene of L. monocytogenes EGD-e. Flanking restriction sites of BglII and KpnI exist on the PnisA and hly 
sides respectively. The six-His-tag codons are underlined. (B) Comparison between the amino acid sequence of native LLO (L. 
monocytogenes EGD-e) with the signal sequence and the constructed six-His-tagged LLO produced in this study.
AGATCT     AGTCTTATAAC……..AAGGAGGCACTCAAA    ATGGGACATCACCATCACCATCACGGATCCGATGCATCT………CAATCGAATAA        GGTACC
BglII site PnisA Promoter N-terminus His-tagged hly KpnIs i t e
MKKIMLVFITLILVSLPIAQQTEAKDASAFNKE……….DNPIE
MGHHHHHHGSDASAFNKE……….DNPIE
Native LLO with signal 
sequence (underlined)
N-terminus His-tagged LLO 
without signal sequence 
(amino acids different from 
the native sequence are 
underlined)
(A)
(B)
AGATCT     AGTCTTATAAC……..AAGGAGGCACTCAAA    ATGGGACATCACCATCACCATCACGGATCCGATGCATCT………CAATCGAATAA        GGTACC
BglII site PnisA Promoter N-terminus His-tagged hly KpnIs i t e
MKKIMLVFITLILVSLPIAQQTEAKDASAFNKE……….DNPIE
MGHHHHHHGSDASAFNKE……….DNPIE
Native LLO with signal 
sequence (underlined)
N-terminus His-tagged LLO 
without signal sequence 
(amino acids different from 
the native sequence are 
underlined)
(A)
(B)Microbial Cell Factories 2008, 7:24 http://www.microbialcellfactories.com/content/7/1/24
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tested by SDS-PAGE for purity (Figure 5) then combined
and dialysed as mentioned earlier. This double sonication
approach increased the total combined yield of LLO to the
range of 9.3–12.9 mg per litre culture (average 11.6 ± 1.56
mg per litre culture). However, when the resulting LLO
was examined by Western blot, minor lower molecular
weight bands appeared below the major LLO band. This
indicated slight degradation of LLO upon the double son-
ication procedure (Figure 6).
To check the functionality of LLO, the haemolytic titre test
was carried out and specific LLO haemolytic activity
ranged from 5 × 105 to 5 × 107 HU per mg total protein.
This haemolytic activity was still detectable after at least 8
months of storage at 4°C.
Discussion
In the present study, we describe the over-expression of
the haemolysin listeriolysin O (LLO) of L. monocytogenes
by the GRAS microorganism L. lactis NZ9000. We used a
well-defined strong promoter system (the NICE system)
in which addition of subinhibitory nisin induces the
PnisA promoter for over-expression of downstream genes
Optimization of nisin concentration for induction experi- ments Figure 3
Optimization of nisin concentration for induction 
experiments. (A) SDS-PAGE of the induction experiment 
for 3 h statically at 30°C without nisin addition (lane 1), and 
using nisin at concentrations of 0.02% (lane 2), 0.1% (lane 3) 
and 0.2% (lane 4) (v/v). Lane 5 represents the protein 
marker. (B) Western blot showing LLO at the expected size 
of about 57 kDa using rabbit anti-LLO as primary antibody.
SDS-PAGE of purified LLO using Ni-NTA affinity chromatog- raphy Figure 4
SDS-PAGE of purified LLO using Ni-NTA affinity 
chromatography. Lane 1 is the protein marker, lane 2 is 
culture lysate of L. lactis NZ9000 (pNZPnisA:CYTO-LLO) 
before passing through the column, lane 3 is the flow-
through of the column, lanes 4 and 5 are two successive 
washes of the columns while lanes 6 and 7 are two succes-
sive elutions showing the purified His-tagged LLO.
SDS-PAGE showing pure LLO elutions (500 ml bacterial cul- ture) using the double sonication approach Figure 5
SDS-PAGE showing pure LLO elutions (500 ml bac-
terial culture) using the double sonication approach. 
Pure LLO was eluted from the Ni-NTA affinity gel after 4 h-
0.2% nisin induction at 30°C and double sonication treatment 
of the induced cells as described in the Methods section. 
Lanes 1–3: elutions after first sonication treatment. Lanes 4–
8: elutions after second sonication treatment.
Western blot showing LLO level and stability after 0.2% nisin  induction Figure 6
Western blot showing LLO level and stability after 
0.2% nisin induction. Left lane, LLO after 3 h induction 
(single sonication); Middle lane, LLO after 4 h induction (sin-
gle sonication); Right lane, LLO after 4 h induction followed 
by the double sonication treatment (few degradation bands 
are observed at slightly lower molecular weights).
50kDa
75kDa
50kDa
75kDaMicrobial Cell Factories 2008, 7:24 http://www.microbialcellfactories.com/content/7/1/24
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[12,13]. In the present work, we utilised a nisin concentra-
tion of 0.2% v/v for induction which maximized LLO pro-
duction and was far below the minimum inhibitory
concentration (MIC) of nisin against the producing strain
(MIC was found to be 3.1% v/v).
The NICE system has been used extensively in the litera-
ture to over-produce proteins in lactococci. For instance,
Brucella abortus GroEL protein was produced in L. lactis
NZ9000 although it was found that only the secreted
rather than the intracellular form was stably produced
suggesting a detrimental effect of GroEL protein on Lacto-
coccus [22]. In contrast, Giardia lamblia cyst wall protein 2
(CWP2) was successfully produced in different cell com-
partments (intracellular, secreted, and cell-surface
anchored) by use of appropriately designed vectors with-
out any detrimental effects on the Lactococcus producer.
Lactococci expressing CWP2 on their surface could elicit
CWP2-specific IgA antibodies and reduced cyst shedding
in a murine Giardia challenge model [23].
Here, we demonstrate the use of the NICE system to suc-
cessfully over-express LLO of L. monocytogenes in the intra-
cellular compartment of L. lactis NZ9000. Several
previous studies examined the over-production of LLO in
different host cells and expression systems (summarized
in Table 3). Earlier studies that purified native LLO
directly from L. monocytogenes culture supernatants had
poor LLO yields (0.022–0.25 mg per litre culture) and uti-
lised laborious multi-step procedures requiring large cul-
ture volumes [24,25]. Dealing with such large culture
volumes of pathogenic bacteria is potentially hazardous
and necessitates special precautions if scaling-up is
required. When LLO was constitutively over-expressed
and secreted by the non-pathogenic Listeria innocua, an
improved yield was obtained (1.6 mg LLO per litre cul-
ture) [26]. However, purification of LLO from L. innocua
involved multiple steps involving preliminary concentra-
tion by filtration, followed by two sequential chromatog-
raphy purification steps [26].
Giammarini and coworkers could inducibly over-express
LLO in E. coli obtaining a relatively good yield (4.5 mg per
litre culture) [15]. However, two sequential purification
steps were applied with haemolytic activity assessment on
blood agar and SDS-PAGE performed between the first
hydroxyapatite purification step and the second ammo-
nium sulphate precipitation step. Further concentration
steps were applied before the effluent fractions containing
LLO were concentrated by ultrafiltration [15]. Although
the LLO yield was good, those multi-step procedures are
relatively time-consuming. To the best of our knowledge,
Churchill et al were able to obtain the highest yield of
haemolytically active LLO [14]. In their study, several
expression systems have been attempted in E. coli among
which the N-terminus His-tagged LLO was the most suc-
cessful using the pQE31/IPTG (Isopropyl β-D-1-thioga-
lactopyranoside)-inducible system (Qiagen). This system
makes use of the well-characterized strong T5 promoter/
lac  operator transcription-translation system to control
LLO expression in E. coli. A significant LLO yield (3.5–8
mg per litre culture) was obtained with proven haemolytic
activity (1.8 × 106 HU per mg protein) and stability up to
one year upon storage at 4°C [14].
Table 3: Comparative results of LLO production and purification by different investigators.
Source of
 LLO
Starter
Culture
volume
   (litre)
LLO yield 
(mg l-1) 
{Total
 yield (mg)}
Specific
LLO
haemolytic
activity (HU
per mg
protein) 
     pH 5.5
Expression host Plasmid expression
system/inducer
  (If applicable)
Reference
Culture supernatant 27 0.022 {0.6} 106 (pH 6) Listeria monocytogenesa N/A [24]
Culture supernatant 3 1.6 {4.8} 1.02 × 106 (pH 5.7) Listeria innocuab pERL3-503
(constitutive)
[26]
Culture supernatant 6 0.25 {1.5} 2.6 × 105 LLO-hypersecretor 
Listeria monocytogenesa
N/A [25]
Cell lysate 1 4.5 {4.5} 1.25 × 106 Escherichia colic pET system/IPTG [15]
Cell lysate 0.6 3.5 – 8 {2.1 – 4.8} 1.8 × 106 Escherichia colid pQE31 system/IPTG [14]
Cell lysate 0.6 2.5 {1.5} 2.16 × 106 Escherichia colie pQE70 system/IPTG [14]
Cell lysate 0.5 -Single sonication 
treatment: 4.43 – 5.9 
{2.215 – 2.95} -Double 
sonication approach: 9.3 – 
12.9 {4.65 – 6.45}
5 × 105 – 5 × 107 Lactococcus lactis 
NZ9000d
NICE system 
(pNZPnisA:CYTO-
LLO)/nisin
This study
(N/A) not applicable; IPTG: Isopropyl β-D-1-thiogalactopyranoside; a untagged native full-length LLO; b untagged full-length LLO; c untagged LLO 
without signal sequence; d N-terminus His-tagged LLO without signal sequence; e C-terminus His-tagged LLO without signal sequenceMicrobial Cell Factories 2008, 7:24 http://www.microbialcellfactories.com/content/7/1/24
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The current L. lactis-based LLO production method resem-
bles to some extent the N-terminus His-tagged LLO pre-
pared by Churchill et al [14]. As regards LLO yield, the
single sonication treatment gave an appreciably good pure
yield (4.43–5.9 mg per litre culture) though the highest
value (i.e. 5.9 mg per litre culture) is less than the highest
yield obtained by Churchill and coworkers (8 mg per litre
culture) [14]. Although the double sonication treatment
of the same culture resulted in some minor degradation of
LLO (Figure 6), the total yield almost doubled (up to 12.9
mg per litre culture) without using any additional culture.
This minor degradation may be tolerable for experimental
scale production (but not for large commercial scale pro-
duction). We also assessed the haemolytic activity of the
purified LLO at intervals up to 8 months and found it to
be within the same range (5 × 105 to 5 × 107 HU per mg
total protein).
We consider the most important innovation in the current
work is the use of L. lactis as an expression host. L. lactis is
a GRAS, Gram-positive lactic acid bacterium widely used
in the food industry. More recently L. lactis has demon-
strated significant promise as a means of producing heter-
ologous proteins for experimental or commercial
applications [8]. Lactic acid bacteria expressing heterolo-
gous proteins have been used in the food industry [27], in
experimental vaccine antigen delivery [11,28], and for the
targeted delivery of therapeutic bioactive proteins
(cytokines and trefoil factors) [10,29]. In producing bio-
active proteins for human or animal use, lactococci have a
significant advantage over E. coli in that they do not pro-
duce endotoxins. Moreover, L. lactis is known to produce
very low amounts of native exoproteins and the lactococ-
cal genome is generally about half the size of the E. coli
genome [9,18,30]. This is an advantage both for in vitro
heterologous protein production and for the use of L. lac-
tis as a vaccine delivery vehicle as there are fewer contam-
inating proteins when L. lactis is used as a heterologous
host [18,31].
Conclusion
The present study offers a convenient method for LLO
production in an advantageous host providing a good
protein yield, high haemolytic activity and significant sta-
bility that compares well with previously published stud-
ies. Purified LLO from L. lactis may find significant
applications in basic research into listerial pathogenesis
including the stimulation and development of improved
monoclonal antibodies against LLO. This L. monocy-
togenes-specific protein may also have applications in the
development of improved food testing protocols. Finally,
L. lactis production of LLO may have applications in vac-
cine development.
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